Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhage

Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhage

AIM: To evaluate visual outcomes of pars plana vitrectomy (PPV) combined with tissue plasminogen activator (tPA)-induced clot lysis and pneumatic displacement for submacular hemorrhage (SMH) in a cohort of closed-globe trauma patients. METHODS: A retrospective, multicenter interventional case series...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wilson X. Wang, Kishan G. Patel, Henok Getahun, Srishti Ramamurthy, Howard Chen, Raja Narayanan, Rajendra S. Apte
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2025-09-01
Series:	International Journal of Ophthalmology
Subjects:	submacular hemorrhage subretinal tissue plasminogen activator clot lysis pneumatic displacement
Online Access:	http://ies.ijo.cn/en_publish/2025/9/20250922.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RtPA for Submacular Hemorrhage
by: Bartosz Zabrzeński, et al.
Published: (2025-07-01)

Comparison of different treatment options in submacular haemorrhage
by: Anna Hillenmayer, et al.
Published: (2024-12-01)

Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products
by: V. D. Gusarova, et al.
Published: (2019-03-01)

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial
by: Timothy L. Jackson, et al.
Published: (2022-01-01)

Comparative outcomes of pars plana vitrectomy with subretinal rt-PA injection in polypoidal choroidal vasculopathy: the role of simultaneous anti-VEGF treatment
by: Lulu Chen, et al.
Published: (2025-07-01)

Trial of Steroids in Retinal Assault: A Case Series
by: Sharanyaa Krishnamoorthy, et al.
Published: (2024-01-01)

Stereotactic fibrinolysis of spontaneous intracerebral hematoma using infusion of recombinant tissue plasminogen activator
by: José Augusto Nasser, et al.
Published: (2002-06-01)

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trial
by: Chan Ning Lee, et al.
Published: (2025-04-01)

Oral Antithrombotic Medication Is Associated with Improved Visual Outcomes in Eyes with Submacular Hemorrhage from Wet Age-Related Macular Degeneration
by: Hemal P. Patel, MD, et al.
Published: (2025-09-01)

In vivo and in silico studies of membrane-stabilizing and clot lysis activities of Trachyspermum ammi
by: Md. Showkoth Akbor, et al.
Published: (2024-12-01)

Incidence of macular hole in patients undergoing pars plana vitrectomy for submacular hemorrhage.
by: Riko Matsumoto, et al.
Published: (2025-01-01)

Effect of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 Levels in the Plasma of Babylon Women with Breast Cancer
by: Sheerin H. Abbas, et al.
Published: (2025-01-01)

Plasminogen deficiency reduces disease severity and immune responses in enterovirus A71-infected mice
by: Zheng-Xun Li, et al.
Published: (2025-07-01)

Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study
by: Romaric De Manfouo Tuono, et al.
Published: (2025-04-01)

The Influence of the Variability of the Profibrinolytic Response of the Blood Vessel Wall on the Effectiveness of Treatment of Primary Open-Angle Glaucoma. Part 3
by: S. I. Makogon, et al.
Published: (2020-06-01)

Plasminogen influence on the PAI-1 release by human platelets
by: O. I. Yusova, et al.
Published: (2024-06-01)

The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study
by: Hanie Khoshtarash, et al.
Published: (2025-07-01)

Tissue Plasminogen Activator Toxicity after Submacular Hemorrhage Repair
by: Yasmin Islam, et al.
Published: (2021-07-01)

Preventing Candida albicans from subverting host plasminogen for invasive infection treatment
by: Si-Min Chen, et al.
Published: (2020-01-01)

Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
by: Latha Ganti, et al.
Published: (2022-02-01)

PLATELET-MEDIATED PLASMINOGEN PROCESSING PRODUCES ANGIOSTATINS: AN IMMUNOCHEMICAL STUDY
by: L.G. Kapustianenko, et al.
Published: (2024-10-01)

ULTRASONIC DETECTION METHOD OF blood plasma FIBRIN CLOT FORMATION MOMENT
by: A. A. Ushakova, et al.
Published: (2019-06-01)

Serum tissue plasminogen activator after cycling with blood flow restriction
by: Josh B Landers, et al.
Published: (2025-02-01)

FabG moonlights as an extracellular adhesin mediates cytoadhesion of Streptococcus suis via interaction with plasminogen
by: Genglin Guo, et al.
Published: (2025-07-01)

Software development for a personalized approach in the treatment of subretinal hemorrhages
by: R.R. Fayzrakhmanov, et al.
Published: (2024-06-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Plasminogen activator inhibitor 1 is a novel predictor in human serum/follicular fluid for diminished ovarian reserve
by: Xinshu Li, et al.
Published: (2025-04-01)

Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients
by: El-Saeid M.E.-S. El-Bawab, et al.
Published: (2023-07-01)

Orolingual angioedema as a complication of systemic thrombolytic therapy with recombinant tissue plasminogen activator
by: E. A. Kovaleva, et al.
Published: (2023-11-01)

Recombinant Plasminogen Activator of the Sandworm (<i>Perinereis aibuhitensis</i>) Expression in <i>Escherichia coli</i>
by: Tuo Song, et al.
Published: (2024-10-01)

Who is in the emergency room matters when we talk about door-to-needle time: a single-center experience
by: Alejandro M. Brunser, et al.
Published: (2023-07-01)

Can serum soluble urokinase plasminogen activator receptor be an effective biomarker in comparing the inflammatory response between laparoscopic and open appendectomy?
by: Basak Erginel, et al.
Published: (2023-06-01)

Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxication
by: Thomas J. Blackmon, et al.
Published: (2025-03-01)

A non‐surgical method for subretinal delivery by trans‐scleral microneedle injection
by: Amir Hejri, et al.
Published: (2025-05-01)

Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury
by: Wenwen Zhang, et al.
Published: (2024-12-01)

Hemostatic profile changes in patients with traumatic brain injury with regard to the genotypes of -675 4G/5G polymorphism of plasminogen activator inhibitor-1 gene
by: O. O. Potapov, et al.
Published: (2016-10-01)

Mesomycoplasma hyopneumoniae lipoprotein Mhp390 serves as a plasminogen receptor mediating extracellular matrix degradation and respiratory epithelial cells injury
by: Wei Liu, et al.
Published: (2025-06-01)

Features of plasminogen activator inhibitor-1 synthesis by local fat depots of different localization in cardiovascular diseases
by: E. V. Belik, et al.
Published: (2022-05-01)

Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study
by: Yi-fan Feng, et al.
Published: (2024-12-01)

Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia
by: Muhammad Said El-Mekkawy, et al.
Published: (2022-02-01)